Tampón de lisis celular
Tampón de lisis celular
Invitrogen™

Tampón de lisis celular

El tampón de lisis celular es un tampón de lisis listo para usar en aplicaciones ELISA y Western blot paraMás información
Have Questions?
Número de catálogoCantidad
FNN0011100 mL
Número de catálogo FNN0011
Precio (CLP)
180.198
Each
Añadir al carro de la compra
Cantidad:
100 mL
Precio (CLP)
180.198
Each
Añadir al carro de la compra
El tampón de lisis celular es un tampón de lisis listo para usar en aplicaciones ELISA y Western blot para la extracción total de proteínas de células de mamíferos. El tampón utiliza lisis basada en detergente, lo que elimina la necesidad de una interrupción celular mecánica, proporcionando una alternativa más suave y fácil al aislar proteínas de cultivos celulares. La formulación ayuda a retener la estructura y función de las proteínas necesarias para los ensayos enzimáticos o los inmunoensayos.

Formulación del tampón: 10 mm de Tris, pH 7,4, 100 mm de NaCl, 1 mm de EDTA, 1 mm de EGTA, 1 mm de NAF, 20 mm de Na4P2O7
2 mm de Na3VO4, 1 % de Triton X-100, 10 % de glicerol, 0,1 % de SDS, 0,5 % de deoxicolato

Este tampón de extracción celular no contiene inhibidores de proteasa y debe suplementarse con 1 mm de PMSF y cóctel inhibidor de proteasa justo antes de su uso.

Ver todos los reactivos y tampones de lisis ELISA disponibles.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Para utilizar con (aplicación)Western Blot, preparación de muestras para ELISA
Tipo de productoTampón para extracto celular
Cantidad100 mL
Condiciones de envíoHielo seco
Unit SizeEach
Contenido y almacenamiento
Almacenar en congelador (de –5 a –30 °C).

Preguntas frecuentes

What extraction reagents are recommended for efficient mouse tissue analysis?

We have 5 different cell and tissue extraction buffers suitable for preparing mouse cell and tissue extracts. These buffers can be used to extract cells and tissues from many other species as well. The exact compositions of all of our buffers are proprietary, but they are similar to those described by many researchers.

Four of these buffers can be used to prepare extracts which can be analyzed with our ELISA and Luminex kits and by Western blotting. Our Cell Extraction Buffer (FNN0011) contains extra phosphatase inhibitors and resembles the RIPA formulation that many people use. Our Tissue Extraction Reagents I (FNN0071) and II (FNN0081) contain different concentrations of NaCl and different surfactants, but are otherwise similar to each other. For those who prefer using an extraction buffer containing the detergent NP-40, we have our NP-40 Lysis Buffer (FNN0021). Finally, we sell a Denaturing Cell Extraction buffer (FNN0091) which contains 3 detergents and a chaotropic agent. Extracts prepared with FNN0091 can be analyzed with our ELISA kits and by Western blotting only. These buffers do not contain protease inhibitors, which the investigator should add right before use.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

During my ProcartaPlex assay data analysis, I am getting a warning message that there is high bead aggregation. What should I do?

Here are possible causes and solutions for this issue:

- Check the protocol settings (make sure you select the correct DD settings).
- Check the level of sheath fluid and empty the waste.
- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, the beads fall below or to the lower left of their bead region on the bead map. Why is this?

Here are possible causes and solutions for this issue:

This usually indicates that the beads have been photobleached. This problem can also be caused by exposing the beads to organic solvents. Unfortunately, the assay will have to be repeated because the beads cannot be restored. The beads must be protected from light and organic solvents.
Alternatively, the instrument may be off in its measurements or you may have a calibration issue. Call the manufacturer for a service appointment.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, beads do not appear in the region gated. What happened?

This indicates that an incorrect buffer was used for the final step. The Wash Solution provided in the kit must be used for washing the beads and the Reading Buffer should be used for resuspending the beads before loading them into the Luminex instrument. The osmolarity of the solution will impact the size of the bead, and any change in the bead size will alter detection by the instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

The bead counts for all of my ProcartaPlex assay wells are erratic. What went wrong?

Here are some suggestions:

- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.
- Review the instrument settings and make sure they are appropriate for the assay being run (adjustment of needle height, make sure you select the correct bead gates and the correct DD settings).
- Shake the plate before acquisition on the instrument to resuspend the beads.
- Vortex the beads for 30 sec before adding them into the plate.
- Washing: Do not forget to keep the plate for about 2 mins on the Hand-Held Magnetic Plate Washer before emptying the plate.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Citations & References (6)

Citations & References
Abstract
Imaging EGFR phosphorylation in intact human pancreatic carcinoma cells.
Authors:Magdeburg R, Kessler M, Boenninghoff R, Keese M,
Journal:In Vivo
PubMed ID:22773576
'Carcinoma of the pancreatic duct is a highly malignant tumor characterized by aggressive and early metastastatic growth. A high rate of tumor recurrence after surgical resection and the lack of effective chemotherapeutic approaches result in low 5-year survival rates. Overexpression of epidermal growth factor (EGF) and its receptor have been ... More
Induction of apoptosis pathways in several cell lines following exposure to the marine algal toxin azaspiracid.
Authors:Twiner MJ, Hanagriff JC, Butler S, Madhkoor AK, Doucette GJ,
Journal:Chem Res Toxicol
PubMed ID:22725096
'Azaspiracids (AZAs) are polyether marine dinoflagellate toxins that accumulate in shellfish and represent an emerging human health risk. Although there have been no deaths associated with the AZA toxins, humans exposed to AZAs experience severe gastrointestinal symptoms. This toxin class has been shown to be highly cytotoxic, a teratogen to ... More
Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells.
Authors:Wu WC, Hu DN, Gao HX, Chen M, Wang D, Rosen R, McCormick SA
Journal:Mol Vis
PubMed ID:21031020
To study the effect of subtoxic levels of hydrogen peroxide (H(2)O(2)) on the expression and release of interleukin-6 (IL-6) by cultured retinal pigment epithelial (RPE) cells and to explore the relevant signal pathways. ... More
Interleukin-1beta increases baseline expression and secretion of interleukin-6 by human uveal melanocytes in vitro via the p38 MAPK/NF-kappaB pathway.
Authors:Hu DN, Chen M, Zhang DY, Ye F, McCormick SA, Chan CC
Journal:Invest Ophthalmol Vis Sci
PubMed ID:21398280
Melanocyte is the major cell component in the uvea. Interleukin (IL)-6 is a proinflammatory cytokine. The authors studied the expression of IL-6 in cultured human uveal melanocytes (UMs) and their modulation by IL-1ß and explored the relevant signal pathways. ... More
Twist modulates human trophoblastic cell invasion via regulation of N-cadherin.
Authors:Ng YH, Zhu H, Leung PC
Journal:Endocrinology
PubMed ID:22166980
The invasion of extravillous cytotrophoblasts (EVT) into the underlying maternal tissues and vasculature is a key step in human placentation. The molecular mechanisms involved in the development of the invasive phenotype of EVT include many that were first discovered for their role in cancer cell metastasis. Previous studies have demonstrated ... More